tecvayli
janssen-cilag international n.v. - teclistamab - mergæxli - Æxlishemjandi lyf - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
oxikodon depot actavis forðatafla 20 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 20 mg
bupropion teva tafla með breyttan losunarhraða 300 mg
teva b.v.* - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 300 mg
oxycodone alvogen (oxycodone ratiopharm) forðatafla 80 mg
alvogen ehf. - oxycodonum hýdróklóríð - forðatafla - 80 mg
aprokam (cefcam) stungulyfsstofn, lausn 50 mg
laboratoires thea* - cefuroximum natríum - stungulyfsstofn, lausn - 50 mg
fentanyl alvogen (fentanyl alvogen) forðaplástur 25 míkróg/klst.
alvogen ehf. - fentanylum inn - forðaplástur - 25 míkróg/klst.
oxikodon depot actavis forðatafla 40 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 40 mg
fentanyl alvogen (fentanyl ratiopharm) forðaplástur 100 míkróg/klst.
alvogen ehf. - fentanylum inn - forðaplástur - 100 míkróg/klst.
oxikodon depot actavis forðatafla 10 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 10 mg
rivaroxaban wh (rivaroxavan pharos) filmuhúðuð tafla 20 mg
williams & halls ehf.* - rivaroxabanum inn - filmuhúðuð tafla - 20 mg